Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Michael Roling"'
Autor:
Anton Škríba, Abdullah M. S. Al-Hatmi, Annelies Verbon, Vladimír Havlíček, Tokameh Mahmoudi, Elisa De Crignis, Mohammad Javad Najafzadeh, Raquel Crespo, Tsung Wai Kan, Renata Ptackova, Robert-Jan Palstra, Miroslav Sulc, Enrico Ne, Joyce Kang, Michael Roling, Casper Rokx, Elizabeth LeMasters, Peter D. Katsikis, Wilfred F. J. van IJcken, Joyce H.G. Lebbink, Sybren de Hoog, Pritha Biswas, Mateusz Stoszko, Yvonne M. Mueller, Alessia Bertoldi
Publikováno v:
Science Advances, 6
Science Advances, 6, 33
Science Advances
Science advances, 6(33):eaha6617. American Association for the Advancement of Science
Science Advances, 6, 33
Science Advances
Science advances, 6(33):eaha6617. American Association for the Advancement of Science
Gliotoxin, identified from a screen of fungal metabolites, disrupts 7SK snRNP, releases P-TEFb, and reverses HIV-1 latency.
A leading pharmacological strategy toward HIV cure requires “shock” or activation of HIV gene expression in latently
A leading pharmacological strategy toward HIV cure requires “shock” or activation of HIV gene expression in latently
Autor:
Pritha Biswas, Mateusz Stoszko, Yvonne M. Mueller, Abdullah M. S. Al-Hatmi, Wilfred F. J. van IJcken, Alessia Bertoldi, Robert-Jan Palstra, Miroslav Sulc, Joyce H.G. Lebbink, Elisa De Crignis, Sybren de Hoog, Raquel Crespo, Enrico Ne, Joyce Kang, Renata Ptackova, Anton Škríba, Peter D. Katsikis, Mohammad Javad Najafzadeh, Tokameh Mahmoudi, Annelies Verbon, Tsung Wai Kan, Vladimír Havlíček, Casper Rokx, Michael Roling
A leading pharmacological strategy towards HIV cure requires “shock” or activation of HIV gene expression in latently infected cells with Latency Reversal Agents (LRAs) followed by their subsequent clearance. In a screen for novel LRAs we used fu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0be8c0054b95ac123f197d740eab2420
https://doi.org/10.1101/848929
https://doi.org/10.1101/848929
Publikováno v:
Advances in Molecular Retrovirology
Persistence of transcriptionally silent replication competent HIV-1 is a major barrier to clearance of the virus from patients; current combinatorial antiretroviral therapies are successful in abrogating active viral replication, but are unable to er
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1a0901ed65eaa6f9aad184213c07253
https://doi.org/10.5772/61948
https://doi.org/10.5772/61948
Autor:
E. De Crignis, A. Mohammed Said Al-Hatmi, Joyce Kang, E. LeMasters, Tokameh Mahmoudi, Peter D. Katsikis, Vladimír Havlíček, T. Wai Kan, S. de Hoog, Y. Müller, Mateusz Stoszko, N.E. Funa, Miroslav Sulc, Michael Roling, A. Bourne
Publikováno v:
Journal of Virus Eradication, Vol 3, Iss, Pp 59-(2017)
Autor:
Michael Röling, Mahsa Mollapour Sisakht, Enrico Ne, Panagiotis Moulos, Raquel Crespo, Mateusz Stoszko, Elisa De Crignis, Helen Bodmer, Tsung Wai Kan, Maryam Akbarzadeh, Vaggelis Harokopos, Pantelis Hatzis, Robert-Jan Palstra, Tokameh Mahmoudi
Publikováno v:
mBio, Vol 12, Iss 6 (2021)
ABSTRACT To identify novel host factors as putative targets to reverse HIV-1 latency, we performed an insertional mutagenesis genetic screen in a latent HIV-1 infected pseudohaploid KBM7 cell line (Hap-Lat). Following mutagenesis, insertions were map
Externí odkaz:
https://doaj.org/article/2f729d806387452999a3c9f51ee0ea9f